nodes	percent_of_prediction	percent_of_DWPC	metapath
Nifedipine—ABCC3—lung cancer	0.154	0.398	CbGaD
Nifedipine—CYP2A6—lung cancer	0.0839	0.216	CbGaD
Nifedipine—CYP2E1—lung cancer	0.0596	0.154	CbGaD
Nifedipine—CYP1A1—lung cancer	0.0587	0.152	CbGaD
Nifedipine—ABCB1—lung cancer	0.0312	0.0805	CbGaD
Nifedipine—ABCC3—Cisplatin—lung cancer	0.0174	0.0464	CbGbCtD
Nifedipine—ABCC3—Etoposide—lung cancer	0.0171	0.0456	CbGbCtD
Nifedipine—CYP1A1—Gefitinib—lung cancer	0.0151	0.0404	CbGbCtD
Nifedipine—ABCC3—Doxorubicin—lung cancer	0.0116	0.0311	CbGbCtD
Nifedipine—ABCC3—Methotrexate—lung cancer	0.0113	0.0301	CbGbCtD
Nifedipine—ABCC2—Paclitaxel—lung cancer	0.00981	0.0262	CbGbCtD
Nifedipine—ABCC2—Irinotecan—lung cancer	0.00967	0.0259	CbGbCtD
Nifedipine—CYP3A5—Gefitinib—lung cancer	0.00908	0.0243	CbGbCtD
Nifedipine—CYP1A1—Erlotinib—lung cancer	0.00894	0.0239	CbGbCtD
Nifedipine—CYP3A5—Teniposide—lung cancer	0.0088	0.0235	CbGbCtD
Nifedipine—ABCC2—Vinblastine—lung cancer	0.0086	0.023	CbGbCtD
Nifedipine—ABCC2—Cisplatin—lung cancer	0.00789	0.0211	CbGbCtD
Nifedipine—ABCC2—Etoposide—lung cancer	0.00775	0.0207	CbGbCtD
Nifedipine—ABCC2—Docetaxel—lung cancer	0.00709	0.0189	CbGbCtD
Nifedipine—CYP3A7—Paclitaxel—lung cancer	0.00655	0.0175	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.00655	0.0175	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.00646	0.0173	CbGbCtD
Nifedipine—CYP3A7—Irinotecan—lung cancer	0.00646	0.0173	CbGbCtD
Nifedipine—ABCB1—Topotecan—lung cancer	0.00646	0.0173	CbGbCtD
Nifedipine—CYP2B6—Irinotecan—lung cancer	0.00615	0.0164	CbGbCtD
Nifedipine—CYP2C9—Gefitinib—lung cancer	0.00609	0.0163	CbGbCtD
Nifedipine—ABCB1—Gefitinib—lung cancer	0.00591	0.0158	CbGbCtD
Nifedipine—CYP2C9—Teniposide—lung cancer	0.0059	0.0158	CbGbCtD
Nifedipine—CYP2D6—Gefitinib—lung cancer	0.00557	0.0149	CbGbCtD
Nifedipine—CYP3A5—Crizotinib—lung cancer	0.00556	0.0149	CbGbCtD
Nifedipine—CYP3A5—Erlotinib—lung cancer	0.00537	0.0143	CbGbCtD
Nifedipine—ABCC2—Doxorubicin—lung cancer	0.00529	0.0141	CbGbCtD
Nifedipine—CYP2C8—Erlotinib—lung cancer	0.00516	0.0138	CbGbCtD
Nifedipine—ABCC2—Methotrexate—lung cancer	0.00512	0.0137	CbGbCtD
Nifedipine—CYP2B6—Cisplatin—lung cancer	0.00501	0.0134	CbGbCtD
Nifedipine—CYP2E1—Etoposide—lung cancer	0.005	0.0134	CbGbCtD
Nifedipine—CYP3A5—Paclitaxel—lung cancer	0.00491	0.0131	CbGbCtD
Nifedipine—CYP3A5—Irinotecan—lung cancer	0.00485	0.013	CbGbCtD
Nifedipine—CYP3A7—Docetaxel—lung cancer	0.00473	0.0127	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.00473	0.0127	CbGbCtD
Nifedipine—CYP2C8—Paclitaxel—lung cancer	0.00472	0.0126	CbGbCtD
Nifedipine—ABCB1—Vinorelbine—lung cancer	0.00455	0.0122	CbGbCtD
Nifedipine—CYP2D6—Vinorelbine—lung cancer	0.00429	0.0115	CbGbCtD
Nifedipine—CYP1A2—Erlotinib—lung cancer	0.00399	0.0107	CbGbCtD
Nifedipine—CYP3A5—Etoposide—lung cancer	0.00388	0.0104	CbGbCtD
Nifedipine—CYP3A4—Topotecan—lung cancer	0.00387	0.0103	CbGbCtD
Nifedipine—CYP2C8—Etoposide—lung cancer	0.00373	0.00997	CbGbCtD
Nifedipine—ABCB1—Crizotinib—lung cancer	0.00362	0.00968	CbGbCtD
Nifedipine—CYP3A5—Docetaxel—lung cancer	0.00355	0.00949	CbGbCtD
Nifedipine—CYP3A4—Gefitinib—lung cancer	0.00354	0.00946	CbGbCtD
Nifedipine—ABCB1—Gemcitabine—lung cancer	0.00354	0.00946	CbGbCtD
Nifedipine—ABCB1—Erlotinib—lung cancer	0.00349	0.00933	CbGbCtD
Nifedipine—CYP3A4—Teniposide—lung cancer	0.00343	0.00917	CbGbCtD
Nifedipine—CYP2B6—Doxorubicin—lung cancer	0.00336	0.00898	CbGbCtD
Nifedipine—CYP2C9—Paclitaxel—lung cancer	0.00329	0.0088	CbGbCtD
Nifedipine—CYP2D6—Erlotinib—lung cancer	0.00329	0.00879	CbGbCtD
Nifedipine—ABCB1—Paclitaxel—lung cancer	0.0032	0.00854	CbGbCtD
Nifedipine—ABCB1—Irinotecan—lung cancer	0.00315	0.00843	CbGbCtD
Nifedipine—CYP1A2—Etoposide—lung cancer	0.00289	0.00772	CbGbCtD
Nifedipine—ABCB1—Vinblastine—lung cancer	0.0028	0.00749	CbGbCtD
Nifedipine—CYP3A4—Vinorelbine—lung cancer	0.00273	0.00729	CbGbCtD
Nifedipine—CYP2C9—Cisplatin—lung cancer	0.00265	0.00708	CbGbCtD
Nifedipine—CYP2D6—Vinblastine—lung cancer	0.00264	0.00706	CbGbCtD
Nifedipine—ABCB1—Cisplatin—lung cancer	0.00257	0.00687	CbGbCtD
Nifedipine—ABCB1—Etoposide—lung cancer	0.00253	0.00675	CbGbCtD
Nifedipine—ABCB1—Docetaxel—lung cancer	0.00231	0.00618	CbGbCtD
Nifedipine—CYP3A4—Crizotinib—lung cancer	0.00217	0.0058	CbGbCtD
Nifedipine—CYP3A4—Erlotinib—lung cancer	0.00209	0.00559	CbGbCtD
Nifedipine—CYP3A4—Paclitaxel—lung cancer	0.00192	0.00512	CbGbCtD
Nifedipine—CYP3A4—Irinotecan—lung cancer	0.00189	0.00505	CbGbCtD
Nifedipine—ABCB1—Doxorubicin—lung cancer	0.00172	0.0046	CbGbCtD
Nifedipine—CYP3A4—Vinblastine—lung cancer	0.00168	0.00449	CbGbCtD
Nifedipine—ABCB1—Methotrexate—lung cancer	0.00167	0.00446	CbGbCtD
Nifedipine—CYP2D6—Doxorubicin—lung cancer	0.00162	0.00434	CbGbCtD
Nifedipine—CYP3A4—Etoposide—lung cancer	0.00151	0.00405	CbGbCtD
Nifedipine—CYP3A4—Docetaxel—lung cancer	0.00138	0.0037	CbGbCtD
Nifedipine—CYP3A4—Doxorubicin—lung cancer	0.00103	0.00276	CbGbCtD
Nifedipine—CACNA2D1—mammary gland—lung cancer	0.000941	0.0515	CbGeAlD
Nifedipine—CALM3—mammary gland—lung cancer	0.000677	0.0371	CbGeAlD
Nifedipine—Nimodipine—AHR—lung cancer	0.000567	0.274	CrCbGaD
Nifedipine—CACNA1C—respiratory system—lung cancer	0.000539	0.0295	CbGeAlD
Nifedipine—CALM1—mammary gland—lung cancer	0.000529	0.029	CbGeAlD
Nifedipine—ABCC3—respiratory system—lung cancer	0.00049	0.0268	CbGeAlD
Nifedipine—CACNB2—cardiac atrium—lung cancer	0.000464	0.0254	CbGeAlD
Nifedipine—CYP2C8—mammary gland—lung cancer	0.000441	0.0241	CbGeAlD
Nifedipine—CACNA1D—cardiac atrium—lung cancer	0.000405	0.0222	CbGeAlD
Nifedipine—CYP2C9—mammary gland—lung cancer	0.000392	0.0214	CbGeAlD
Nifedipine—CACNA1C—cardiac atrium—lung cancer	0.000374	0.0205	CbGeAlD
Nifedipine—CALM3—bronchus—lung cancer	0.000372	0.0203	CbGeAlD
Nifedipine—CACNA2D1—bone marrow—lung cancer	0.000368	0.0201	CbGeAlD
Nifedipine—CACNB2—lung—lung cancer	0.000355	0.0194	CbGeAlD
Nifedipine—CALM2—respiratory system—lung cancer	0.000354	0.0194	CbGeAlD
Nifedipine—CALM1—respiratory system—lung cancer	0.000353	0.0193	CbGeAlD
Nifedipine—CALM3—trachea—lung cancer	0.000334	0.0183	CbGeAlD
Nifedipine—CACNA2D1—lung—lung cancer	0.000333	0.0182	CbGeAlD
Nifedipine—CALM3—cardiac atrium—lung cancer	0.000313	0.0171	CbGeAlD
Nifedipine—CACNA1D—lung—lung cancer	0.00031	0.017	CbGeAlD
Nifedipine—CALM2—epithelium—lung cancer	0.000296	0.0162	CbGeAlD
Nifedipine—CALM1—epithelium—lung cancer	0.000295	0.0161	CbGeAlD
Nifedipine—CALM2—bronchus—lung cancer	0.000292	0.016	CbGeAlD
Nifedipine—CALM1—bronchus—lung cancer	0.00029	0.0159	CbGeAlD
Nifedipine—CACNA1C—lung—lung cancer	0.000286	0.0157	CbGeAlD
Nifedipine—CYP2A6—lung—lung cancer	0.000278	0.0152	CbGeAlD
Nifedipine—CYP1A2—respiratory system—lung cancer	0.000275	0.015	CbGeAlD
Nifedipine—CYP1A1—respiratory system—lung cancer	0.000271	0.0148	CbGeAlD
Nifedipine—CYP3A5—respiratory system—lung cancer	0.000265	0.0145	CbGeAlD
Nifedipine—CALM3—bone marrow—lung cancer	0.000265	0.0145	CbGeAlD
Nifedipine—CYP2B6—respiratory system—lung cancer	0.000264	0.0144	CbGeAlD
Nifedipine—CALM2—trachea—lung cancer	0.000262	0.0143	CbGeAlD
Nifedipine—CALM1—trachea—lung cancer	0.000261	0.0143	CbGeAlD
Nifedipine—ABCC3—lung—lung cancer	0.00026	0.0142	CbGeAlD
Nifedipine—CACNA1H—lymph node—lung cancer	0.000257	0.0141	CbGeAlD
Nifedipine—CYP2E1—respiratory system—lung cancer	0.000247	0.0135	CbGeAlD
Nifedipine—CALM2—cardiac atrium—lung cancer	0.000246	0.0135	CbGeAlD
Nifedipine—CALM1—cardiac atrium—lung cancer	0.000245	0.0134	CbGeAlD
Nifedipine—Nilvadipine—CYP2A6—lung cancer	0.000243	0.118	CrCbGaD
Nifedipine—CACNB2—lymph node—lung cancer	0.000243	0.0133	CbGeAlD
Nifedipine—CALM3—lung—lung cancer	0.00024	0.0131	CbGeAlD
Nifedipine—CACNA2D1—lymph node—lung cancer	0.000228	0.0125	CbGeAlD
Nifedipine—CYP1A1—epithelium—lung cancer	0.000227	0.0124	CbGeAlD
Nifedipine—CYP1A1—bronchus—lung cancer	0.000223	0.0122	CbGeAlD
Nifedipine—CYP2B6—bronchus—lung cancer	0.000217	0.0119	CbGeAlD
Nifedipine—CACNA1D—lymph node—lung cancer	0.000212	0.0116	CbGeAlD
Nifedipine—Amlodipine—CYP2A6—lung cancer	0.000209	0.101	CrCbGaD
Nifedipine—CALM2—bone marrow—lung cancer	0.000208	0.0114	CbGeAlD
Nifedipine—CALM1—bone marrow—lung cancer	0.000207	0.0113	CbGeAlD
Nifedipine—CYP1A1—trachea—lung cancer	0.0002	0.011	CbGeAlD
Nifedipine—CACNA1C—lymph node—lung cancer	0.000196	0.0107	CbGeAlD
Nifedipine—Clevidipine—CYP2E1—lung cancer	0.000193	0.0931	CrCbGaD
Nifedipine—CYP1A1—cardiac atrium—lung cancer	0.000188	0.0103	CbGeAlD
Nifedipine—CALM2—lung—lung cancer	0.000188	0.0103	CbGeAlD
Nifedipine—CALM1—lung—lung cancer	0.000187	0.0103	CbGeAlD
Nifedipine—ABCC3—lymph node—lung cancer	0.000178	0.00974	CbGeAlD
Nifedipine—Nilvadipine—CYP2E1—lung cancer	0.000173	0.0835	CrCbGaD
Nifedipine—CALM3—lymph node—lung cancer	0.000164	0.00897	CbGeAlD
Nifedipine—Amlodipine—CYP1A1—lung cancer	0.000147	0.0709	CrCbGaD
Nifedipine—CYP1A2—lung—lung cancer	0.000146	0.00799	CbGeAlD
Nifedipine—CYP1A1—lung—lung cancer	0.000144	0.00788	CbGeAlD
Nifedipine—ABCC2—lymph node—lung cancer	0.000142	0.00778	CbGeAlD
Nifedipine—ABCB1—respiratory system—lung cancer	0.000141	0.00771	CbGeAlD
Nifedipine—CYP3A5—lung—lung cancer	0.000141	0.0077	CbGeAlD
Nifedipine—CYP2B6—lung—lung cancer	0.00014	0.00766	CbGeAlD
Nifedipine—CYP2E1—lung—lung cancer	0.000131	0.00719	CbGeAlD
Nifedipine—Nicardipine—CYP2E1—lung cancer	0.000131	0.0633	CrCbGaD
Nifedipine—CALM2—lymph node—lung cancer	0.000129	0.00704	CbGeAlD
Nifedipine—CALM1—lymph node—lung cancer	0.000128	0.00701	CbGeAlD
Nifedipine—ABCB1—epithelium—lung cancer	0.000118	0.00644	CbGeAlD
Nifedipine—ABCB1—trachea—lung cancer	0.000104	0.0057	CbGeAlD
Nifedipine—CYP1A1—lymph node—lung cancer	9.85e-05	0.00539	CbGeAlD
Nifedipine—Nisoldipine—ABCB1—lung cancer	9.68e-05	0.0468	CrCbGaD
Nifedipine—Nitrendipine—ABCB1—lung cancer	9.05e-05	0.0438	CrCbGaD
Nifedipine—ABCB1—bone marrow—lung cancer	8.26e-05	0.00452	CbGeAlD
Nifedipine—Amlodipine—ABCB1—lung cancer	7.8e-05	0.0377	CrCbGaD
Nifedipine—ABCB1—lung—lung cancer	7.48e-05	0.00409	CbGeAlD
Nifedipine—Felodipine—ABCB1—lung cancer	7.21e-05	0.0348	CrCbGaD
Nifedipine—Nicardipine—ABCB1—lung cancer	6.86e-05	0.0332	CrCbGaD
Nifedipine—ABCB1—lymph node—lung cancer	5.12e-05	0.0028	CbGeAlD
Nifedipine—Constipation—Paclitaxel—lung cancer	3.66e-05	0.000314	CcSEcCtD
Nifedipine—Confusional state—Docetaxel—lung cancer	3.66e-05	0.000314	CcSEcCtD
Nifedipine—Pharyngitis—Methotrexate—lung cancer	3.65e-05	0.000313	CcSEcCtD
Nifedipine—Urinary tract disorder—Methotrexate—lung cancer	3.63e-05	0.000312	CcSEcCtD
Nifedipine—Photosensitivity reaction—Doxorubicin—lung cancer	3.63e-05	0.000312	CcSEcCtD
Nifedipine—Anaphylactic shock—Docetaxel—lung cancer	3.63e-05	0.000311	CcSEcCtD
Nifedipine—Oedema—Docetaxel—lung cancer	3.63e-05	0.000311	CcSEcCtD
Nifedipine—Weight increased—Doxorubicin—lung cancer	3.62e-05	0.000311	CcSEcCtD
Nifedipine—Pruritus—Gemcitabine—lung cancer	3.62e-05	0.00031	CcSEcCtD
Nifedipine—Urethral disorder—Methotrexate—lung cancer	3.61e-05	0.000309	CcSEcCtD
Nifedipine—Weight decreased—Doxorubicin—lung cancer	3.6e-05	0.000309	CcSEcCtD
Nifedipine—Feeling abnormal—Etoposide—lung cancer	3.6e-05	0.000309	CcSEcCtD
Nifedipine—Hyperglycaemia—Doxorubicin—lung cancer	3.59e-05	0.000308	CcSEcCtD
Nifedipine—Diarrhoea—Irinotecan—lung cancer	3.59e-05	0.000308	CcSEcCtD
Nifedipine—Gastrointestinal pain—Etoposide—lung cancer	3.57e-05	0.000306	CcSEcCtD
Nifedipine—Shock—Docetaxel—lung cancer	3.57e-05	0.000306	CcSEcCtD
Nifedipine—Nervous system disorder—Docetaxel—lung cancer	3.56e-05	0.000305	CcSEcCtD
Nifedipine—Thrombocytopenia—Docetaxel—lung cancer	3.55e-05	0.000305	CcSEcCtD
Nifedipine—Visual impairment—Methotrexate—lung cancer	3.55e-05	0.000304	CcSEcCtD
Nifedipine—Tachycardia—Docetaxel—lung cancer	3.54e-05	0.000304	CcSEcCtD
Nifedipine—Feeling abnormal—Paclitaxel—lung cancer	3.53e-05	0.000302	CcSEcCtD
Nifedipine—Skin disorder—Docetaxel—lung cancer	3.52e-05	0.000302	CcSEcCtD
Nifedipine—Stevens-Johnson syndrome—Doxorubicin—lung cancer	3.52e-05	0.000302	CcSEcCtD
Nifedipine—Hypersensitivity—Cisplatin—lung cancer	3.51e-05	0.000301	CcSEcCtD
Nifedipine—Gastrointestinal pain—Paclitaxel—lung cancer	3.5e-05	0.0003	CcSEcCtD
Nifedipine—Diarrhoea—Gemcitabine—lung cancer	3.5e-05	0.0003	CcSEcCtD
Nifedipine—Erythema multiforme—Methotrexate—lung cancer	3.48e-05	0.000298	CcSEcCtD
Nifedipine—Dizziness—Irinotecan—lung cancer	3.47e-05	0.000298	CcSEcCtD
Nifedipine—Urticaria—Etoposide—lung cancer	3.47e-05	0.000297	CcSEcCtD
Nifedipine—Jaundice—Doxorubicin—lung cancer	3.46e-05	0.000297	CcSEcCtD
Nifedipine—Anorexia—Docetaxel—lung cancer	3.46e-05	0.000297	CcSEcCtD
Nifedipine—Abdominal pain—Etoposide—lung cancer	3.45e-05	0.000296	CcSEcCtD
Nifedipine—Body temperature increased—Etoposide—lung cancer	3.45e-05	0.000296	CcSEcCtD
Nifedipine—Conjunctivitis—Doxorubicin—lung cancer	3.45e-05	0.000296	CcSEcCtD
Nifedipine—Eye disorder—Methotrexate—lung cancer	3.44e-05	0.000295	CcSEcCtD
Nifedipine—Tinnitus—Methotrexate—lung cancer	3.43e-05	0.000294	CcSEcCtD
Nifedipine—Asthenia—Cisplatin—lung cancer	3.42e-05	0.000293	CcSEcCtD
Nifedipine—Cardiac disorder—Methotrexate—lung cancer	3.42e-05	0.000293	CcSEcCtD
Nifedipine—Sweating—Doxorubicin—lung cancer	3.4e-05	0.000292	CcSEcCtD
Nifedipine—Urticaria—Paclitaxel—lung cancer	3.4e-05	0.000292	CcSEcCtD
Nifedipine—Hypotension—Docetaxel—lung cancer	3.39e-05	0.000291	CcSEcCtD
Nifedipine—Haematuria—Doxorubicin—lung cancer	3.38e-05	0.00029	CcSEcCtD
Nifedipine—Body temperature increased—Paclitaxel—lung cancer	3.38e-05	0.00029	CcSEcCtD
Nifedipine—Abdominal pain—Paclitaxel—lung cancer	3.38e-05	0.00029	CcSEcCtD
Nifedipine—Hepatobiliary disease—Doxorubicin—lung cancer	3.36e-05	0.000288	CcSEcCtD
Nifedipine—Epistaxis—Doxorubicin—lung cancer	3.35e-05	0.000287	CcSEcCtD
Nifedipine—Angiopathy—Methotrexate—lung cancer	3.34e-05	0.000286	CcSEcCtD
Nifedipine—Vomiting—Irinotecan—lung cancer	3.34e-05	0.000286	CcSEcCtD
Nifedipine—Sinusitis—Doxorubicin—lung cancer	3.33e-05	0.000286	CcSEcCtD
Nifedipine—Immune system disorder—Methotrexate—lung cancer	3.32e-05	0.000285	CcSEcCtD
Nifedipine—Mediastinal disorder—Methotrexate—lung cancer	3.32e-05	0.000284	CcSEcCtD
Nifedipine—Agranulocytosis—Doxorubicin—lung cancer	3.31e-05	0.000284	CcSEcCtD
Nifedipine—Rash—Irinotecan—lung cancer	3.31e-05	0.000284	CcSEcCtD
Nifedipine—Dermatitis—Irinotecan—lung cancer	3.31e-05	0.000284	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Docetaxel—lung cancer	3.3e-05	0.000283	CcSEcCtD
Nifedipine—Chills—Methotrexate—lung cancer	3.3e-05	0.000283	CcSEcCtD
Nifedipine—Headache—Irinotecan—lung cancer	3.29e-05	0.000282	CcSEcCtD
Nifedipine—Insomnia—Docetaxel—lung cancer	3.28e-05	0.000281	CcSEcCtD
Nifedipine—Diarrhoea—Cisplatin—lung cancer	3.26e-05	0.00028	CcSEcCtD
Nifedipine—Paraesthesia—Docetaxel—lung cancer	3.26e-05	0.000279	CcSEcCtD
Nifedipine—Alopecia—Methotrexate—lung cancer	3.25e-05	0.000279	CcSEcCtD
Nifedipine—Vomiting—Gemcitabine—lung cancer	3.25e-05	0.000279	CcSEcCtD
Nifedipine—Bradycardia—Doxorubicin—lung cancer	3.24e-05	0.000278	CcSEcCtD
Nifedipine—Dyspnoea—Docetaxel—lung cancer	3.23e-05	0.000277	CcSEcCtD
Nifedipine—Somnolence—Docetaxel—lung cancer	3.22e-05	0.000277	CcSEcCtD
Nifedipine—Mental disorder—Methotrexate—lung cancer	3.22e-05	0.000277	CcSEcCtD
Nifedipine—Rash—Gemcitabine—lung cancer	3.22e-05	0.000276	CcSEcCtD
Nifedipine—Dermatitis—Gemcitabine—lung cancer	3.22e-05	0.000276	CcSEcCtD
Nifedipine—Hypersensitivity—Etoposide—lung cancer	3.22e-05	0.000276	CcSEcCtD
Nifedipine—Malnutrition—Methotrexate—lung cancer	3.2e-05	0.000275	CcSEcCtD
Nifedipine—Erythema—Methotrexate—lung cancer	3.2e-05	0.000275	CcSEcCtD
Nifedipine—Haemoglobin—Doxorubicin—lung cancer	3.2e-05	0.000275	CcSEcCtD
Nifedipine—Headache—Gemcitabine—lung cancer	3.2e-05	0.000275	CcSEcCtD
Nifedipine—Rhinitis—Doxorubicin—lung cancer	3.19e-05	0.000274	CcSEcCtD
Nifedipine—Dyspepsia—Docetaxel—lung cancer	3.19e-05	0.000274	CcSEcCtD
Nifedipine—Haemorrhage—Doxorubicin—lung cancer	3.19e-05	0.000273	CcSEcCtD
Nifedipine—Hepatitis—Doxorubicin—lung cancer	3.19e-05	0.000273	CcSEcCtD
Nifedipine—Hypoaesthesia—Doxorubicin—lung cancer	3.17e-05	0.000272	CcSEcCtD
Nifedipine—Pharyngitis—Doxorubicin—lung cancer	3.16e-05	0.000271	CcSEcCtD
Nifedipine—Decreased appetite—Docetaxel—lung cancer	3.15e-05	0.00027	CcSEcCtD
Nifedipine—Hypersensitivity—Paclitaxel—lung cancer	3.15e-05	0.00027	CcSEcCtD
Nifedipine—Urinary tract disorder—Doxorubicin—lung cancer	3.15e-05	0.00027	CcSEcCtD
Nifedipine—Oedema peripheral—Doxorubicin—lung cancer	3.14e-05	0.000269	CcSEcCtD
Nifedipine—Dysgeusia—Methotrexate—lung cancer	3.14e-05	0.000269	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Docetaxel—lung cancer	3.13e-05	0.000269	CcSEcCtD
Nifedipine—Asthenia—Etoposide—lung cancer	3.13e-05	0.000269	CcSEcCtD
Nifedipine—Connective tissue disorder—Doxorubicin—lung cancer	3.13e-05	0.000269	CcSEcCtD
Nifedipine—Fatigue—Docetaxel—lung cancer	3.13e-05	0.000268	CcSEcCtD
Nifedipine—Urethral disorder—Doxorubicin—lung cancer	3.12e-05	0.000268	CcSEcCtD
Nifedipine—Nausea—Irinotecan—lung cancer	3.12e-05	0.000267	CcSEcCtD
Nifedipine—Pain—Docetaxel—lung cancer	3.1e-05	0.000266	CcSEcCtD
Nifedipine—Constipation—Docetaxel—lung cancer	3.1e-05	0.000266	CcSEcCtD
Nifedipine—Back pain—Methotrexate—lung cancer	3.1e-05	0.000266	CcSEcCtD
Nifedipine—Pruritus—Etoposide—lung cancer	3.09e-05	0.000265	CcSEcCtD
Nifedipine—Visual impairment—Doxorubicin—lung cancer	3.07e-05	0.000263	CcSEcCtD
Nifedipine—Asthenia—Paclitaxel—lung cancer	3.07e-05	0.000263	CcSEcCtD
Nifedipine—Nausea—Gemcitabine—lung cancer	3.04e-05	0.00026	CcSEcCtD
Nifedipine—Vomiting—Cisplatin—lung cancer	3.03e-05	0.00026	CcSEcCtD
Nifedipine—Pruritus—Paclitaxel—lung cancer	3.03e-05	0.00026	CcSEcCtD
Nifedipine—Vision blurred—Methotrexate—lung cancer	3.02e-05	0.000259	CcSEcCtD
Nifedipine—Erythema multiforme—Doxorubicin—lung cancer	3.01e-05	0.000258	CcSEcCtD
Nifedipine—Rash—Cisplatin—lung cancer	3e-05	0.000258	CcSEcCtD
Nifedipine—Dermatitis—Cisplatin—lung cancer	3e-05	0.000257	CcSEcCtD
Nifedipine—Feeling abnormal—Docetaxel—lung cancer	2.99e-05	0.000256	CcSEcCtD
Nifedipine—Diarrhoea—Etoposide—lung cancer	2.99e-05	0.000256	CcSEcCtD
Nifedipine—Eye disorder—Doxorubicin—lung cancer	2.98e-05	0.000255	CcSEcCtD
Nifedipine—Ill-defined disorder—Methotrexate—lung cancer	2.97e-05	0.000255	CcSEcCtD
Nifedipine—Tinnitus—Doxorubicin—lung cancer	2.97e-05	0.000255	CcSEcCtD
Nifedipine—Gastrointestinal pain—Docetaxel—lung cancer	2.97e-05	0.000254	CcSEcCtD
Nifedipine—Anaemia—Methotrexate—lung cancer	2.96e-05	0.000254	CcSEcCtD
Nifedipine—Flushing—Doxorubicin—lung cancer	2.96e-05	0.000254	CcSEcCtD
Nifedipine—Cardiac disorder—Doxorubicin—lung cancer	2.96e-05	0.000254	CcSEcCtD
Nifedipine—Diarrhoea—Paclitaxel—lung cancer	2.93e-05	0.000251	CcSEcCtD
Nifedipine—Angiopathy—Doxorubicin—lung cancer	2.89e-05	0.000248	CcSEcCtD
Nifedipine—Malaise—Methotrexate—lung cancer	2.89e-05	0.000248	CcSEcCtD
Nifedipine—Dizziness—Etoposide—lung cancer	2.89e-05	0.000248	CcSEcCtD
Nifedipine—Immune system disorder—Doxorubicin—lung cancer	2.88e-05	0.000247	CcSEcCtD
Nifedipine—Vertigo—Methotrexate—lung cancer	2.88e-05	0.000247	CcSEcCtD
Nifedipine—Mediastinal disorder—Doxorubicin—lung cancer	2.87e-05	0.000246	CcSEcCtD
Nifedipine—Abdominal pain—Docetaxel—lung cancer	2.87e-05	0.000246	CcSEcCtD
Nifedipine—Body temperature increased—Docetaxel—lung cancer	2.87e-05	0.000246	CcSEcCtD
Nifedipine—Leukopenia—Methotrexate—lung cancer	2.87e-05	0.000246	CcSEcCtD
Nifedipine—Chills—Doxorubicin—lung cancer	2.86e-05	0.000245	CcSEcCtD
Nifedipine—Arrhythmia—Doxorubicin—lung cancer	2.85e-05	0.000244	CcSEcCtD
Nifedipine—Dizziness—Paclitaxel—lung cancer	2.83e-05	0.000243	CcSEcCtD
Nifedipine—Nausea—Cisplatin—lung cancer	2.83e-05	0.000243	CcSEcCtD
Nifedipine—Alopecia—Doxorubicin—lung cancer	2.82e-05	0.000242	CcSEcCtD
Nifedipine—Cough—Methotrexate—lung cancer	2.8e-05	0.00024	CcSEcCtD
Nifedipine—Mental disorder—Doxorubicin—lung cancer	2.79e-05	0.000239	CcSEcCtD
Nifedipine—Vomiting—Etoposide—lung cancer	2.78e-05	0.000238	CcSEcCtD
Nifedipine—Erythema—Doxorubicin—lung cancer	2.77e-05	0.000238	CcSEcCtD
Nifedipine—Malnutrition—Doxorubicin—lung cancer	2.77e-05	0.000238	CcSEcCtD
Nifedipine—Rash—Etoposide—lung cancer	2.75e-05	0.000236	CcSEcCtD
Nifedipine—Dermatitis—Etoposide—lung cancer	2.75e-05	0.000236	CcSEcCtD
Nifedipine—Headache—Etoposide—lung cancer	2.73e-05	0.000235	CcSEcCtD
Nifedipine—Flatulence—Doxorubicin—lung cancer	2.73e-05	0.000234	CcSEcCtD
Nifedipine—Chest pain—Methotrexate—lung cancer	2.73e-05	0.000234	CcSEcCtD
Nifedipine—Arthralgia—Methotrexate—lung cancer	2.73e-05	0.000234	CcSEcCtD
Nifedipine—Myalgia—Methotrexate—lung cancer	2.73e-05	0.000234	CcSEcCtD
Nifedipine—Tension—Doxorubicin—lung cancer	2.72e-05	0.000233	CcSEcCtD
Nifedipine—Vomiting—Paclitaxel—lung cancer	2.72e-05	0.000233	CcSEcCtD
Nifedipine—Dysgeusia—Doxorubicin—lung cancer	2.72e-05	0.000233	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	2.71e-05	0.000232	CcSEcCtD
Nifedipine—Rash—Paclitaxel—lung cancer	2.7e-05	0.000231	CcSEcCtD
Nifedipine—Dermatitis—Paclitaxel—lung cancer	2.7e-05	0.000231	CcSEcCtD
Nifedipine—Discomfort—Methotrexate—lung cancer	2.69e-05	0.000231	CcSEcCtD
Nifedipine—Nervousness—Doxorubicin—lung cancer	2.69e-05	0.000231	CcSEcCtD
Nifedipine—Back pain—Doxorubicin—lung cancer	2.68e-05	0.00023	CcSEcCtD
Nifedipine—Headache—Paclitaxel—lung cancer	2.68e-05	0.00023	CcSEcCtD
Nifedipine—Hypersensitivity—Docetaxel—lung cancer	2.67e-05	0.000229	CcSEcCtD
Nifedipine—Muscle spasms—Doxorubicin—lung cancer	2.67e-05	0.000229	CcSEcCtD
Nifedipine—Confusional state—Methotrexate—lung cancer	2.64e-05	0.000226	CcSEcCtD
Nifedipine—Anaphylactic shock—Methotrexate—lung cancer	2.61e-05	0.000224	CcSEcCtD
Nifedipine—Vision blurred—Doxorubicin—lung cancer	2.61e-05	0.000224	CcSEcCtD
Nifedipine—Asthenia—Docetaxel—lung cancer	2.6e-05	0.000223	CcSEcCtD
Nifedipine—Nausea—Etoposide—lung cancer	2.59e-05	0.000222	CcSEcCtD
Nifedipine—Ill-defined disorder—Doxorubicin—lung cancer	2.57e-05	0.000221	CcSEcCtD
Nifedipine—Pruritus—Docetaxel—lung cancer	2.57e-05	0.00022	CcSEcCtD
Nifedipine—Nervous system disorder—Methotrexate—lung cancer	2.56e-05	0.00022	CcSEcCtD
Nifedipine—Anaemia—Doxorubicin—lung cancer	2.56e-05	0.00022	CcSEcCtD
Nifedipine—Thrombocytopenia—Methotrexate—lung cancer	2.56e-05	0.00022	CcSEcCtD
Nifedipine—Agitation—Doxorubicin—lung cancer	2.55e-05	0.000219	CcSEcCtD
Nifedipine—Nausea—Paclitaxel—lung cancer	2.54e-05	0.000218	CcSEcCtD
Nifedipine—Skin disorder—Methotrexate—lung cancer	2.54e-05	0.000218	CcSEcCtD
Nifedipine—Hyperhidrosis—Methotrexate—lung cancer	2.53e-05	0.000217	CcSEcCtD
Nifedipine—Malaise—Doxorubicin—lung cancer	2.5e-05	0.000215	CcSEcCtD
Nifedipine—Vertigo—Doxorubicin—lung cancer	2.49e-05	0.000214	CcSEcCtD
Nifedipine—Anorexia—Methotrexate—lung cancer	2.49e-05	0.000214	CcSEcCtD
Nifedipine—Syncope—Doxorubicin—lung cancer	2.49e-05	0.000213	CcSEcCtD
Nifedipine—Leukopenia—Doxorubicin—lung cancer	2.48e-05	0.000213	CcSEcCtD
Nifedipine—Diarrhoea—Docetaxel—lung cancer	2.48e-05	0.000213	CcSEcCtD
Nifedipine—Palpitations—Doxorubicin—lung cancer	2.45e-05	0.00021	CcSEcCtD
Nifedipine—Hypotension—Methotrexate—lung cancer	2.44e-05	0.00021	CcSEcCtD
Nifedipine—Loss of consciousness—Doxorubicin—lung cancer	2.44e-05	0.000209	CcSEcCtD
Nifedipine—Cough—Doxorubicin—lung cancer	2.42e-05	0.000208	CcSEcCtD
Nifedipine—Dizziness—Docetaxel—lung cancer	2.4e-05	0.000206	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Methotrexate—lung cancer	2.38e-05	0.000204	CcSEcCtD
Nifedipine—Insomnia—Methotrexate—lung cancer	2.36e-05	0.000203	CcSEcCtD
Nifedipine—Chest pain—Doxorubicin—lung cancer	2.36e-05	0.000203	CcSEcCtD
Nifedipine—Myalgia—Doxorubicin—lung cancer	2.36e-05	0.000203	CcSEcCtD
Nifedipine—Arthralgia—Doxorubicin—lung cancer	2.36e-05	0.000203	CcSEcCtD
Nifedipine—Anxiety—Doxorubicin—lung cancer	2.35e-05	0.000202	CcSEcCtD
Nifedipine—Paraesthesia—Methotrexate—lung cancer	2.35e-05	0.000201	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	2.35e-05	0.000201	CcSEcCtD
Nifedipine—Discomfort—Doxorubicin—lung cancer	2.33e-05	0.0002	CcSEcCtD
Nifedipine—Dyspnoea—Methotrexate—lung cancer	2.33e-05	0.0002	CcSEcCtD
Nifedipine—Somnolence—Methotrexate—lung cancer	2.32e-05	0.000199	CcSEcCtD
Nifedipine—Dry mouth—Doxorubicin—lung cancer	2.31e-05	0.000198	CcSEcCtD
Nifedipine—Vomiting—Docetaxel—lung cancer	2.31e-05	0.000198	CcSEcCtD
Nifedipine—Dyspepsia—Methotrexate—lung cancer	2.3e-05	0.000197	CcSEcCtD
Nifedipine—Rash—Docetaxel—lung cancer	2.29e-05	0.000196	CcSEcCtD
Nifedipine—Dermatitis—Docetaxel—lung cancer	2.29e-05	0.000196	CcSEcCtD
Nifedipine—Confusional state—Doxorubicin—lung cancer	2.28e-05	0.000196	CcSEcCtD
Nifedipine—Decreased appetite—Methotrexate—lung cancer	2.27e-05	0.000195	CcSEcCtD
Nifedipine—Headache—Docetaxel—lung cancer	2.27e-05	0.000195	CcSEcCtD
Nifedipine—Anaphylactic shock—Doxorubicin—lung cancer	2.26e-05	0.000194	CcSEcCtD
Nifedipine—Oedema—Doxorubicin—lung cancer	2.26e-05	0.000194	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Methotrexate—lung cancer	2.26e-05	0.000194	CcSEcCtD
Nifedipine—Fatigue—Methotrexate—lung cancer	2.25e-05	0.000193	CcSEcCtD
Nifedipine—Pain—Methotrexate—lung cancer	2.24e-05	0.000192	CcSEcCtD
Nifedipine—Shock—Doxorubicin—lung cancer	2.23e-05	0.000191	CcSEcCtD
Nifedipine—Nervous system disorder—Doxorubicin—lung cancer	2.22e-05	0.00019	CcSEcCtD
Nifedipine—Thrombocytopenia—Doxorubicin—lung cancer	2.22e-05	0.00019	CcSEcCtD
Nifedipine—Tachycardia—Doxorubicin—lung cancer	2.21e-05	0.00019	CcSEcCtD
Nifedipine—Skin disorder—Doxorubicin—lung cancer	2.2e-05	0.000189	CcSEcCtD
Nifedipine—Hyperhidrosis—Doxorubicin—lung cancer	2.19e-05	0.000188	CcSEcCtD
Nifedipine—Anorexia—Doxorubicin—lung cancer	2.16e-05	0.000185	CcSEcCtD
Nifedipine—Nausea—Docetaxel—lung cancer	2.15e-05	0.000185	CcSEcCtD
Nifedipine—Feeling abnormal—Methotrexate—lung cancer	2.15e-05	0.000185	CcSEcCtD
Nifedipine—Gastrointestinal pain—Methotrexate—lung cancer	2.14e-05	0.000183	CcSEcCtD
Nifedipine—Hypotension—Doxorubicin—lung cancer	2.12e-05	0.000181	CcSEcCtD
Nifedipine—Urticaria—Methotrexate—lung cancer	2.08e-05	0.000178	CcSEcCtD
Nifedipine—Abdominal pain—Methotrexate—lung cancer	2.07e-05	0.000177	CcSEcCtD
Nifedipine—Body temperature increased—Methotrexate—lung cancer	2.07e-05	0.000177	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.06e-05	0.000177	CcSEcCtD
Nifedipine—Insomnia—Doxorubicin—lung cancer	2.05e-05	0.000176	CcSEcCtD
Nifedipine—Paraesthesia—Doxorubicin—lung cancer	2.03e-05	0.000174	CcSEcCtD
Nifedipine—Dyspnoea—Doxorubicin—lung cancer	2.02e-05	0.000173	CcSEcCtD
Nifedipine—Somnolence—Doxorubicin—lung cancer	2.01e-05	0.000173	CcSEcCtD
Nifedipine—Dyspepsia—Doxorubicin—lung cancer	1.99e-05	0.000171	CcSEcCtD
Nifedipine—Decreased appetite—Doxorubicin—lung cancer	1.97e-05	0.000169	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Doxorubicin—lung cancer	1.95e-05	0.000168	CcSEcCtD
Nifedipine—Fatigue—Doxorubicin—lung cancer	1.95e-05	0.000167	CcSEcCtD
Nifedipine—Pain—Doxorubicin—lung cancer	1.94e-05	0.000166	CcSEcCtD
Nifedipine—Constipation—Doxorubicin—lung cancer	1.94e-05	0.000166	CcSEcCtD
Nifedipine—Hypersensitivity—Methotrexate—lung cancer	1.93e-05	0.000165	CcSEcCtD
Nifedipine—Asthenia—Methotrexate—lung cancer	1.88e-05	0.000161	CcSEcCtD
Nifedipine—Feeling abnormal—Doxorubicin—lung cancer	1.87e-05	0.00016	CcSEcCtD
Nifedipine—Gastrointestinal pain—Doxorubicin—lung cancer	1.85e-05	0.000159	CcSEcCtD
Nifedipine—Pruritus—Methotrexate—lung cancer	1.85e-05	0.000159	CcSEcCtD
Nifedipine—Urticaria—Doxorubicin—lung cancer	1.8e-05	0.000154	CcSEcCtD
Nifedipine—Body temperature increased—Doxorubicin—lung cancer	1.79e-05	0.000153	CcSEcCtD
Nifedipine—Abdominal pain—Doxorubicin—lung cancer	1.79e-05	0.000153	CcSEcCtD
Nifedipine—Diarrhoea—Methotrexate—lung cancer	1.79e-05	0.000153	CcSEcCtD
Nifedipine—Dizziness—Methotrexate—lung cancer	1.73e-05	0.000148	CcSEcCtD
Nifedipine—Hypersensitivity—Doxorubicin—lung cancer	1.67e-05	0.000143	CcSEcCtD
Nifedipine—Vomiting—Methotrexate—lung cancer	1.66e-05	0.000143	CcSEcCtD
Nifedipine—Rash—Methotrexate—lung cancer	1.65e-05	0.000141	CcSEcCtD
Nifedipine—Dermatitis—Methotrexate—lung cancer	1.65e-05	0.000141	CcSEcCtD
Nifedipine—Headache—Methotrexate—lung cancer	1.64e-05	0.00014	CcSEcCtD
Nifedipine—Asthenia—Doxorubicin—lung cancer	1.62e-05	0.000139	CcSEcCtD
Nifedipine—Pruritus—Doxorubicin—lung cancer	1.6e-05	0.000137	CcSEcCtD
Nifedipine—Nausea—Methotrexate—lung cancer	1.55e-05	0.000133	CcSEcCtD
Nifedipine—Diarrhoea—Doxorubicin—lung cancer	1.55e-05	0.000133	CcSEcCtD
Nifedipine—Dizziness—Doxorubicin—lung cancer	1.5e-05	0.000128	CcSEcCtD
Nifedipine—Vomiting—Doxorubicin—lung cancer	1.44e-05	0.000123	CcSEcCtD
Nifedipine—Rash—Doxorubicin—lung cancer	1.43e-05	0.000122	CcSEcCtD
Nifedipine—Dermatitis—Doxorubicin—lung cancer	1.43e-05	0.000122	CcSEcCtD
Nifedipine—Headache—Doxorubicin—lung cancer	1.42e-05	0.000122	CcSEcCtD
Nifedipine—Nausea—Doxorubicin—lung cancer	1.34e-05	0.000115	CcSEcCtD
Nifedipine—CYP2D6—Metabolism—PIK3CG—lung cancer	1.01e-06	9.95e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CD—lung cancer	1e-06	9.91e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CD—lung cancer	1e-06	9.91e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—SRC—lung cancer	1e-06	9.88e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—SRC—lung cancer	1e-06	9.88e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CG—lung cancer	9.99e-07	9.87e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—MAPK3—lung cancer	9.99e-07	9.86e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—MAPK3—lung cancer	9.99e-07	9.86e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—STAT3—lung cancer	9.98e-07	9.85e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—NRAS—lung cancer	9.95e-07	9.83e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—CREBBP—lung cancer	9.91e-07	9.79e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—KRAS—lung cancer	9.82e-07	9.7e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—KRAS—lung cancer	9.82e-07	9.7e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—EGFR—lung cancer	9.82e-07	9.7e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GSTP1—lung cancer	9.65e-07	9.54e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—STAT3—lung cancer	9.65e-07	9.53e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—STAT3—lung cancer	9.65e-07	9.53e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—NRAS—lung cancer	9.63e-07	9.51e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—NRAS—lung cancer	9.63e-07	9.51e-06	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PTEN—lung cancer	9.6e-07	9.48e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—POMC—lung cancer	9.59e-07	9.47e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—MAPK3—lung cancer	9.53e-07	9.41e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—POMC—lung cancer	9.51e-07	9.39e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—EGFR—lung cancer	9.5e-07	9.38e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—EGFR—lung cancer	9.5e-07	9.38e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3CB—lung cancer	9.4e-07	9.29e-06	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PTEN—lung cancer	9.4e-07	9.29e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CD—lung cancer	9.4e-07	9.28e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CAT—lung cancer	9.39e-07	9.28e-06	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PTEN—lung cancer	9.38e-07	9.27e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—APOA1—lung cancer	9.35e-07	9.24e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—CREBBP—lung cancer	9.34e-07	9.23e-06	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PTEN—lung cancer	9.34e-07	9.23e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—PIK3CA—lung cancer	9.33e-07	9.21e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PTGS2—lung cancer	9.32e-07	9.2e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MDM2—lung cancer	9.29e-07	9.18e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—ALB—lung cancer	9.28e-07	9.17e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—KRAS—lung cancer	9.28e-07	9.16e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—MYC—lung cancer	9.27e-07	9.16e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—CREBBP—lung cancer	9.26e-07	9.15e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—RAF1—lung cancer	9.26e-07	9.15e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—MAPK3—lung cancer	9.22e-07	9.11e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—MAPK3—lung cancer	9.22e-07	9.11e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—ERBB2—lung cancer	9.16e-07	9.05e-06	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—PIK3CA—lung cancer	9.16e-07	9.04e-06	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—EP300—lung cancer	9.15e-07	9.04e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ABCB1—lung cancer	9.14e-07	9.03e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—EGFR—lung cancer	9.07e-07	8.96e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MTOR—lung cancer	9.04e-07	8.93e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CB—lung cancer	9.04e-07	8.93e-06	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PTEN—lung cancer	9.04e-07	8.93e-06	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PTEN—lung cancer	9.04e-07	8.93e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—PIK3CA—lung cancer	9.02e-07	8.91e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—PIK3CA—lung cancer	9.02e-07	8.91e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MDM2—lung cancer	8.99e-07	8.88e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MDM2—lung cancer	8.99e-07	8.88e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—TYMS—lung cancer	8.98e-07	8.87e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—KRAS—lung cancer	8.97e-07	8.86e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—KRAS—lung cancer	8.97e-07	8.86e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—MYC—lung cancer	8.97e-07	8.86e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—MYC—lung cancer	8.97e-07	8.86e-06	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—EP300—lung cancer	8.97e-07	8.86e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—RAF1—lung cancer	8.96e-07	8.85e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—RAF1—lung cancer	8.96e-07	8.85e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.95e-07	8.84e-06	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—EP300—lung cancer	8.95e-07	8.84e-06	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—EP300—lung cancer	8.91e-07	8.8e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GSTM1—lung cancer	8.87e-07	8.76e-06	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PTEN—lung cancer	8.86e-07	8.76e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—ERBB2—lung cancer	8.86e-07	8.75e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—ERBB2—lung cancer	8.86e-07	8.75e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CD—lung cancer	8.86e-07	8.75e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CD—lung cancer	8.78e-07	8.67e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—EGFR—lung cancer	8.77e-07	8.66e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—EGFR—lung cancer	8.77e-07	8.66e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MTOR—lung cancer	8.74e-07	8.64e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CB—lung cancer	8.74e-07	8.64e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MTOR—lung cancer	8.74e-07	8.64e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CB—lung cancer	8.74e-07	8.64e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—ALB—lung cancer	8.74e-07	8.64e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CXCL8—lung cancer	8.69e-07	8.58e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—ALB—lung cancer	8.67e-07	8.56e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—HRAS—lung cancer	8.63e-07	8.52e-06	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—EP300—lung cancer	8.62e-07	8.51e-06	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—EP300—lung cancer	8.62e-07	8.51e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—KRAS—lung cancer	8.57e-07	8.46e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CG—lung cancer	8.54e-07	8.43e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—PIK3CA—lung cancer	8.52e-07	8.42e-06	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—EP300—lung cancer	8.45e-07	8.35e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CYP1A1—lung cancer	8.41e-07	8.31e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CXCL8—lung cancer	8.4e-07	8.3e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CXCL8—lung cancer	8.4e-07	8.3e-06	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—PIK3CA—lung cancer	8.39e-07	8.29e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—HRAS—lung cancer	8.35e-07	8.25e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—HRAS—lung cancer	8.35e-07	8.25e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ERCC2—lung cancer	8.34e-07	8.24e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CASP3—lung cancer	8.31e-07	8.21e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IL2—lung cancer	8.3e-07	8.2e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—KRAS—lung cancer	8.29e-07	8.18e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—KRAS—lung cancer	8.29e-07	8.18e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—IL6—lung cancer	8.26e-07	8.16e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—PIK3CA—lung cancer	8.24e-07	8.14e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—PIK3CA—lung cancer	8.24e-07	8.14e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CB—lung cancer	8.19e-07	8.09e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PTEN—lung cancer	8.13e-07	8.03e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—POMC—lung cancer	8.12e-07	8.03e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PTGS2—lung cancer	8.12e-07	8.02e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CCND1—lung cancer	8.09e-07	7.99e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—JUN—lung cancer	8.08e-07	7.98e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CASP3—lung cancer	8.04e-07	7.94e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CASP3—lung cancer	8.04e-07	7.94e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IL2—lung cancer	8.03e-07	7.93e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IL2—lung cancer	8.03e-07	7.93e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—IL6—lung cancer	7.99e-07	7.89e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—IL6—lung cancer	7.99e-07	7.89e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CREBBP—lung cancer	7.91e-07	7.82e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—HRAS—lung cancer	7.89e-07	7.79e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—PIK3CA—lung cancer	7.87e-07	7.77e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MMP9—lung cancer	7.86e-07	7.76e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CDKN1A—lung cancer	7.83e-07	7.73e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CCND1—lung cancer	7.83e-07	7.73e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CCND1—lung cancer	7.83e-07	7.73e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—JUN—lung cancer	7.81e-07	7.72e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—JUN—lung cancer	7.81e-07	7.72e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PTEN—lung cancer	7.81e-07	7.72e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—EP300—lung cancer	7.75e-07	7.66e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CB—lung cancer	7.72e-07	7.63e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CB—lung cancer	7.65e-07	7.56e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PTGS2—lung cancer	7.65e-07	7.56e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—HRAS—lung cancer	7.63e-07	7.53e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—HRAS—lung cancer	7.63e-07	7.53e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—AKT1—lung cancer	7.62e-07	7.53e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—PIK3CA—lung cancer	7.61e-07	7.52e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—PIK3CA—lung cancer	7.61e-07	7.52e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MMP9—lung cancer	7.6e-07	7.51e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MMP9—lung cancer	7.6e-07	7.51e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PTGS2—lung cancer	7.58e-07	7.49e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CDKN1A—lung cancer	7.57e-07	7.48e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CDKN1A—lung cancer	7.57e-07	7.48e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PTEN—lung cancer	7.56e-07	7.46e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PTEN—lung cancer	7.56e-07	7.46e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IL6—lung cancer	7.55e-07	7.45e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CD—lung cancer	7.5e-07	7.41e-06	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—AKT1—lung cancer	7.48e-07	7.39e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—EP300—lung cancer	7.45e-07	7.36e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—ALB—lung cancer	7.41e-07	7.32e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—AKT1—lung cancer	7.37e-07	7.28e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—AKT1—lung cancer	7.37e-07	7.28e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IL6—lung cancer	7.3e-07	7.21e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IL6—lung cancer	7.3e-07	7.21e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—HRAS—lung cancer	7.28e-07	7.19e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—SRC—lung cancer	7.24e-07	7.16e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—APOA1—lung cancer	7.22e-07	7.13e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—EP300—lung cancer	7.21e-07	7.12e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—EP300—lung cancer	7.21e-07	7.12e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PTEN—lung cancer	7.08e-07	6.99e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—VEGFA—lung cancer	7.06e-07	6.97e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—HRAS—lung cancer	7.04e-07	6.96e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—HRAS—lung cancer	7.04e-07	6.96e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—SRC—lung cancer	7.01e-07	6.92e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—SRC—lung cancer	7.01e-07	6.92e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—STAT3—lung cancer	6.99e-07	6.9e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—NRAS—lung cancer	6.97e-07	6.88e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—IL6—lung cancer	6.97e-07	6.88e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—AKT1—lung cancer	6.96e-07	6.88e-06	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—AKT1—lung cancer	6.86e-07	6.77e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—VEGFA—lung cancer	6.82e-07	6.74e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—VEGFA—lung cancer	6.82e-07	6.74e-06	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PIK3CA—lung cancer	6.77e-07	6.69e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—STAT3—lung cancer	6.76e-07	6.68e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—STAT3—lung cancer	6.76e-07	6.68e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—EP300—lung cancer	6.75e-07	6.67e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—NRAS—lung cancer	6.74e-07	6.66e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—NRAS—lung cancer	6.74e-07	6.66e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—IL6—lung cancer	6.74e-07	6.66e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—IL6—lung cancer	6.74e-07	6.66e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—AKT1—lung cancer	6.74e-07	6.65e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—AKT1—lung cancer	6.74e-07	6.65e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MAPK3—lung cancer	6.67e-07	6.59e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PTEN—lung cancer	6.67e-07	6.59e-06	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PIK3CA—lung cancer	6.63e-07	6.55e-06	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PIK3CA—lung cancer	6.62e-07	6.54e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PTEN—lung cancer	6.61e-07	6.53e-06	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PIK3CA—lung cancer	6.59e-07	6.51e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CG—lung cancer	6.59e-07	6.51e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CB—lung cancer	6.54e-07	6.46e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MYC—lung cancer	6.49e-07	6.41e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PTGS2—lung cancer	6.48e-07	6.4e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MAPK3—lung cancer	6.46e-07	6.38e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MAPK3—lung cancer	6.46e-07	6.38e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—AKT1—lung cancer	6.43e-07	6.35e-06	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PIK3CA—lung cancer	6.37e-07	6.3e-06	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PIK3CA—lung cancer	6.37e-07	6.3e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—EP300—lung cancer	6.36e-07	6.28e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—EGFR—lung cancer	6.35e-07	6.27e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—EP300—lung cancer	6.31e-07	6.23e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MYC—lung cancer	6.28e-07	6.2e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MYC—lung cancer	6.28e-07	6.2e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—POMC—lung cancer	6.27e-07	6.19e-06	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PIK3CA—lung cancer	6.25e-07	6.18e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—AKT1—lung cancer	6.22e-07	6.14e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—AKT1—lung cancer	6.22e-07	6.14e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—EGFR—lung cancer	6.14e-07	6.07e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—EGFR—lung cancer	6.14e-07	6.07e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CREBBP—lung cancer	6.11e-07	6.03e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—KRAS—lung cancer	6e-07	5.92e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—KRAS—lung cancer	5.8e-07	5.73e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—KRAS—lung cancer	5.8e-07	5.73e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CD—lung cancer	5.79e-07	5.72e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3CA—lung cancer	5.73e-07	5.66e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ALB—lung cancer	5.72e-07	5.65e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PTEN—lung cancer	5.65e-07	5.58e-06	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—AKT1—lung cancer	5.53e-07	5.46e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CA—lung cancer	5.51e-07	5.44e-06	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—AKT1—lung cancer	5.42e-07	5.35e-06	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—AKT1—lung cancer	5.41e-07	5.34e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—EP300—lung cancer	5.39e-07	5.32e-06	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—AKT1—lung cancer	5.38e-07	5.32e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TP53—lung cancer	5.33e-07	5.27e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CA—lung cancer	5.33e-07	5.27e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CA—lung cancer	5.33e-07	5.27e-06	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—AKT1—lung cancer	5.21e-07	5.14e-06	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—AKT1—lung cancer	5.21e-07	5.14e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TP53—lung cancer	5.16e-07	5.09e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TP53—lung cancer	5.16e-07	5.09e-06	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—AKT1—lung cancer	5.11e-07	5.05e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—HRAS—lung cancer	5.1e-07	5.04e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CB—lung cancer	5.05e-07	4.99e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTGS2—lung cancer	5e-07	4.94e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CA—lung cancer	4.99e-07	4.93e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—HRAS—lung cancer	4.93e-07	4.87e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—HRAS—lung cancer	4.93e-07	4.87e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IL6—lung cancer	4.88e-07	4.82e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IL6—lung cancer	4.72e-07	4.66e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IL6—lung cancer	4.72e-07	4.66e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CA—lung cancer	4.71e-07	4.65e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—AKT1—lung cancer	4.68e-07	4.63e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CA—lung cancer	4.67e-07	4.61e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—AKT1—lung cancer	4.5e-07	4.45e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTEN—lung cancer	4.36e-07	4.31e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—AKT1—lung cancer	4.35e-07	4.3e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—AKT1—lung cancer	4.35e-07	4.3e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—EP300—lung cancer	4.16e-07	4.11e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—AKT1—lung cancer	4.08e-07	4.03e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CA—lung cancer	3.99e-07	3.94e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—AKT1—lung cancer	3.84e-07	3.8e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—AKT1—lung cancer	3.81e-07	3.76e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—AKT1—lung cancer	3.26e-07	3.22e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CA—lung cancer	3.08e-07	3.04e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—AKT1—lung cancer	2.51e-07	2.48e-06	CbGpPWpGaD
